Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann’s thrombasthenia

References

• AbshireTKenetGRecombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitorsJ Thromb Haemost2004289990915140125
   PubMed Web of Science ®Google Scholar
• AledortLMComparative thrombotic event incidence after infusion of recombinant factor VIIa versus factor VIII inhibitor bypass activityJ Thromb Haemost2004217000815456478
   PubMed Web of Science ®Google Scholar
• AlmeidaAMKhairKHannIThe use of recombinant factor VIIa in children with inherited platelet function disordersBr J Haematol20031214778112716372
   PubMed Web of Science ®Google Scholar
• BellJASavidgeGFGlanzmann’s thrombasthenia proposed optimal management during surgery and deliveryClin Appl Thromb Hemost200391677012812388
   PubMed Web of Science ®Google Scholar
• BerrettiniMMarianiGSchiavoniMPharmacokinetic evaluation of recombinant, activated factor VII in patients with inherited factor VII deficiencyHaematologica200186640511418374
   PubMed Web of Science ®Google Scholar
• CaglarKCetinkayaAAytacSUse of recombinant factor VIIa for bleeding in children with Glanzmann thrombastheniaPediatr Hematol Oncol200320435814631616
   PubMed Web of Science ®Google Scholar
• ChuansumritASangkapreechaCHathiratPSuccessful epistaxis control in a patient with Glanzmann thrombasthenia by increased bolus injection dose of recombinant factor VIIaThromb Haemost199982177810613676
   PubMed Web of Science ®Google Scholar
• ChuansumritASuwannuraksMSri-UdompornNRecombinant activated factor VII combined with local measures in preventing bleeding from invasive dental procedures in patients with Glanzmann thrombastheniaBlood Coagul Fibrinolysis2003141879012632030
   PubMed Web of Science ®Google Scholar
• CoppolaATufanoACiminoERecombinant factor VIIa in a patient with Glanzmann’s thrombasthenia undergoing gynecological surgery: open issues in light of successful treatmentThromb Haemost2004921450215583755
   PubMed Web of Science ®Google Scholar
• d’OironRMenartCTrzeciakMCUse of recombinant factor VIIa in 3 patients with inherited type I Glanzmann’s thrombasthenia undergoing invasive proceduresThromb Haemost200083644710823254
   PubMed Web of Science ®Google Scholar
• DargaudYBordetJCTrzeciakMCA case of Glanzmann’s thrombasthenia successfully treated with recombinant factor VIIa during a surgical procedure: observations on the monitoring and the mechanism of action of this drugHaematologica2006916 Suppl172016434366
   PubMedGoogle Scholar
• DeveciogluOUnuvarAAnakSPyelolithotomy in a patient with Glanzmann thrombasthenia and antiglycoprotein IIb/IIIa antibodies: the shortest possible duration of treatment with recombinant activated factor VII and platelet transfusionsTurk J Pediatr20034564612718376
   PubMed Web of Science ®Google Scholar
• DinessVBregengaardCErhardtsenERecombinant human factor VIIa (rFVIIa) in a rabbit stasis modelThromb Res199267233411440525
   PubMed Web of Science ®Google Scholar
• DoddRYNotariEPStramerSLCurrent prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor populationTransfusion200242975912385406
   PubMed Web of Science ®Google Scholar
• FressinaudESigaud-FiksMLe BoterffCUse of recombinant factor VIIa (NovoSeven®) for dental extraction in a patient affected by platelet-type (pseudo-) von Willebrand disease (Abstract)Haemophilia19984299
   Google Scholar
• GeorgeJNCaenJPNurdenATGlanzmann’s thrombasthenia: the spectrum of clinical diseaseBlood1990751383952180491
   PubMed Web of Science ®Google Scholar
• HoffmanMMonroeDMIIIRobertsHRActivated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VIIBlood Coagul Fibrinolysis19989Suppl 1S6159819030
   PubMed Web of Science ®Google Scholar
• InagakiMMoriTTsunematsuYUse of recombinant activated factor VII to control bleeding in a young child with qualitative platelet disorder: a case reportBlood Coagul Fibrinolysis2006173172216651876
   PubMed Web of Science ®Google Scholar
• ItoKYoshidaHHatoyamaHAntibody removal therapy used successfully at delivery of a pregnant patient with Glanzmann’s thrombasthenia and multiple anti-platelet antibodiesVox Sang1991614061949709
   PubMed Web of Science ®Google Scholar
• JacobsMRPalavecinoEYomtovianRDon’t bug me: the problem of bacterial contamination of blood components – challenges and solutionsTransfusion2001411331411724974
   PubMed Web of Science ®Google Scholar
• JurlanderBThimLKlausenNKRecombinant activated factor VII (rFVIIa): characterization, manufacturing, and clinical developmentSemin Thromb Hemost2001273738411547359
   PubMed Web of Science ®Google Scholar
• KaleABayhanGYalinkayaAThe use of recombinant factor VIla in a primigravida with Glanzmann’s thrombasthenia during deliveryJ Perinat Med200432456815493726
   PubMed Web of Science ®Google Scholar
• KaleelrahmanMMinfordAParapiaLAUse of recombinant factor VIIa in inherited platelet disordersBr J Haematol200412595615015980
   PubMed Web of Science ®Google Scholar
• KenetGLubetskybALuboshitzJA new approach to treatment of bleeding episodes in young hemophilia patients: a single bolus megadose of recombinant activated factor VII (NovoSeven)J Thromb Haemost20031450512871449
   PubMed Web of Science ®Google Scholar
• LangendonckLAppelIMModification of biological parameters after treatment with recombinant factor VIIa in a patient with thrombocytopathy due to storage pool diseasePediatr Blood Cancer200544676815714444
   PubMed Web of Science ®Google Scholar
• LindleyCMSawyerWTMacikBGPharmacokinetics and pharmacodynamics of recombinant factor VIIaClin Pharmacol Ther199455638488004880
   PubMed Web of Science ®Google Scholar
• LismanTAdelmeijerJHeijnenFRecombinant factor VIIa restores aggregation of alphaIIbbeta3-deficient platelets via tissue factor-independent fibrin generationBlood20041031720714592825
   PubMed Web of Science ®Google Scholar
• LismanTMoschatsisSAdelmeijerJRecombinant factor VIIa enhances deposition of platelets with congenital or acquired alpha IIb beta 3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor-independent thrombin generationBlood200310118647012411291
   PubMed Web of Science ®Google Scholar
• LombardoVTSottilottaGRecombinant activated factor VII combined with desmopressin in preventing bleeding from dental extraction in a patient with Glanzmann’s thrombastheniaClin Appl Thromb Hemost2006121151616444446
   PubMed Web of Science ®Google Scholar
• LusherJMEarly treatment with recombinant factor VIIa results in greater efficacy with less productEur J Haematol Suppl1998637109882925
   PubMedGoogle Scholar
• LusherJMAcute hemarthroses: the benefits of early versus late treatment with recombinant activated factor VIIBlood Coagul Fibrinolysis200011Suppl 1S45910850564
   PubMed Web of Science ®Google Scholar
• MartinIKriaaFProulleVProtein A Sepharose immunoadsorption can restore the efficacy of platelet concentrates in patients with Glanzmann’s thrombasthenia and anti-glycoprotein IIb-IIIa antibodiesBr J Haematol2002119991712472579
   PubMed Web of Science ®Google Scholar
• MayerSABrunNCBegtrupKRecombinant activated factor VII for acute intracerebral hemorrhageN Engl J Med20053527778515728810
   PubMed Web of Science ®Google Scholar
• McGregorLHanssMSayeghAAggregation to thrombin and collagen of platelets from a Glanzmann thrombasthenic patient lacking glycoproteins IIb and IIIaThromb Haemost19896296272595666
   PubMed Web of Science ®Google Scholar
• MonroeDMHoffmanMOliverJAPlatelet activity of high-dose factor VIIa is independent of tissue factorBr J Haematol19979954279401063
   PubMed Web of Science ®Google Scholar
• MonteSLyonsGPeripartum management of a patient with Glanzmann’s thrombasthenia using ThrombelastographBr J Anaesth200288734812067020
   PubMed Web of Science ®Google Scholar
• MorrisseyJHMutchNJColmanREMarderVJClowesAWGeorgeJNGoldhaberSZTissue factor structure and function. Hemostasis and ThrombosisBasic Principles and Clinical Practice20065PhiladelphiaLippincott Williams & Wilkins91106
   Google Scholar
• MussoRCultreraDRussoMRecombinant activated factor VII as haemostatic agent in Glanzmann’s thrombasthenia (Abstract)Thromb Haemost199982Suppl621
   Google Scholar
• NiewiarowskiSLevy-ToledanoSCaenJPPlatelet interaction with polymerizing fibrin in Glanzmann’s thrombastheniaThromb Res198123457637324007
   PubMed Web of Science ®Google Scholar
• NurdenATInherited abnormalities of plateletsThromb Haemost1999824688010605738
   PubMed Web of Science ®Google Scholar
• O’ConnellKAWoodJJWiseRPThromboembolic adverse events after use of recombinant human coagulation factor VIIaJAMA2006295293816418464
   PubMed Web of Science ®Google Scholar
• OsdoitSRosaJ-PPolymeric fibrin interacts with platelets independently from integrin αIIβ3 (Abstract)Blood200198518a
   Web of Science ®Google Scholar
• OzeloMCSvirinPLarinaLUse of recombinant factor VIIa in the management of severe bleeding episodes in patients with Bernard-Soulier syndromeAnn Hematol2005848162216044315
   PubMed Web of Science ®Google Scholar
• PeerschkeEIZuckerMBGrantRACorrelation between fibrinogen binding to human platelets and platelet aggregabilityBlood19805584176767512
   PubMed Web of Science ®Google Scholar
• PetersMHeijboerHTreatment of a patient with Bernard-Soulier, syndrome and recurrent nosebleeds with recombinant factor VIIa [letter]Thromb Haemost1998803529716174
   PubMed Web of Science ®Google Scholar
• PhillipsDRCharoIFPariseLVThe platelet membrane glycoprotein IIb-IIIa complexBlood198871831432833328
   PubMed Web of Science ®Google Scholar
• PoonM-CMichelsonAAFactor VIIaPlatelets20062BostonElsevier Science125161
   Google Scholar
• PoonM-Cd’OironRvon DepkaMProphylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann’s thrombasthenia: results of an international surveyJ Thromb Haemost20042109610315219192
   PubMed Web of Science ®Google Scholar
• PoonM-CDemersCJobinFRecombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombastheniaBlood1999943951310572113
   PubMed Web of Science ®Google Scholar
• PoonM-CZotzRDiMinnoGGlanzmann’s thrombasthenia treatment: a prospective observational registry on the use of recombinant human activated factor VII and other hemostatic agentsSemin Hematol200643S33616427383
   PubMed Web of Science ®Google Scholar
• Pozo PozoAIJimenez-YusteVVillarASuccessful thyroidectomy in a patient with Hermansky-Pudlak syndrome treated with recombinant activated factor VII and platelet concentratesBlood Coagul Fibrinolysis200213551312192307
   PubMed Web of Science ®Google Scholar
• ReverterJCBeguinSKesselsHInhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and “clinical restenosis”J Clin Invest199698863748698879
   PubMed Web of Science ®Google Scholar
• RobinsonKLSavoiaHStreetAMThrombotic complications in two patients receiving NovoSeven® (Abstract)Haemophilia20006349
   Google Scholar
• SallahSIsaksenMSeremetisSComparative thrombotic event incidence after infusion of recombinant factor VIIa vs. factor VIII inhibitor bypass activity – a rebuttalJ Thromb Haemost20053820215842389
   PubMed Web of Science ®Google Scholar
• SantagostinoEGringeriAMannucciPMHome treatment with recombinant activated factor VII in patients with factor VIII inhibitors: the advantages of early interventionBr J Haematol199910422610027707
   PubMed Web of Science ®Google Scholar
• TengbornLPetrusonBA patient with Glanzmann thrombasthenia and epistaxis successfully treated with recombinant factor VIIa [letter]Thromb Haemost19967598128822604
   PubMed Web of Science ®Google Scholar
• TurecekPLRichterGMuchitschEMThrombogenicity of recombinant factor VIIa and recombinant soluble tissue factor in an in vivo rabbit model (Abstract)Thromb Haemost199778Suppl222
   Google Scholar
• UzunlarHIErogluASenelACA patient with Glanzmann’s thrombasthenia for emergent abdominal surgeryAnesth Analg20049912586015385386
   PubMed Web of Science ®Google Scholar
• van BuurenHRWielengaJJSuccessful surgery using recombinant factor VIIa for recurrent, idiopathic nonulcer duodenal bleeding in a patient with Glanzmann’s thrombastheniaDig Dis Sci2002472134612353868
   PubMed Web of Science ®Google Scholar
• VillarAAronisSMorfiniMPharmacokinetics of activated recombinant coagulation factor VII (NovoSeven) in children vs. adults with haemophilia AHaemophilia200410352915230949
   PubMed Web of Science ®Google Scholar
• YilmazBTAliogluBOzyurekESuccessful use of recombinant factor VIIa (NovoSeven) during cardiac surgery in a pediatric patient with Glanzmann thrombastheniaPediatr Cardiol200526843515690232
   PubMed Web of Science ®Google Scholar